Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

manilatimes.net · 2026-08-11

FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ('Sanara,” 'Sanara MedTech,” the 'Company,” 'we,” 'our” or 'us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the second quarter ended June 30, 2026.

TickrTrends take: Sanara MedTech Inc., which trades under the ticker MDXG, released its unaudited second quarter 2026 financial results as a healthcare sector company currently assessed as overvalued by TickrTrends metrics. For investors focused on valuation, the key question is whether these quarterly results demonstrate sufficient earnings growth or margin expansion to justify the current market price relative to fundamental metrics. Readers should examine whether the company's revenue trajectory and profitability trends show meaningful improvement that could realign the stock with its valuation multiples.

Read the full story at manilatimes.net →